[Protective effect of drugs on myocardial cells in acute myocardial infarct].
D000208:Acute Disease; D004338:Drug Combinations; D005947:Glucose / Q000008:administration & dosage; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage; D008353:Mannitol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D009206:Myocardium / Q000473:pathology; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011188:Potassium / Q000008:administration & dosage; D011433:Propranolol / Q000627:therapeutic use
D004338:Drug Combinations; D007328:Insulin; D009599:Nitroprusside; D008353:Mannitol; D011433:Propranolol; D005996:Nitroglycerin; D005947:Glucose; D011188:Potassium; D010646:Phentolamine
Ochronne działanie leków na komórki mieśnia serca w ostrym okresie zawału.